We are live on
!
Find out more
AC
AltraVue Capital Portfolio holdings
AUM
$1.16B
1-Year Est. Return
46.45%
This Fund
S&P 500
This Quarter
Est. Return
+9.58%
1 Year Est. Return
+46.45%
3 Year Est. Return
+174.8%
5 Year Est. Return
+275.79%
10 Year Est. Return
–
AUM
$564M
AUM Growth
+$112M
(+25%)
Cap. Flow
+$76.5M
Cap. Flow
% of AUM
13.56%
Top 10 Holdings %
Top 10 Hldgs %
52.53%
Holding
35
New
2
Increased
27
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
StoneX
SNEX
|
+$21.9M |
| 2 |
BGC Group
BGC
|
+$13.2M |
| 3 |
Concrete Pumping Holdings
BBCP
|
+$8.25M |
| 4 |
CCF
Chase Corporation
CCF
|
+$4.41M |
| 5 |
QADA
QAD Inc.
QADA
|
+$4.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMTC
Bryn Mawr Bank Corp
BMTC
|
+$18.2M |
| 2 |
Lifecore Biomedical
LFCR
|
+$4.07M |
| 3 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$3.27M |
| 4 |
SIGA Technologies
SIGA
|
+$1.97M |
| 5 |
BRC Group Holdings
RILY
|
+$56.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.62% |
| 2 | Healthcare | 18.41% |
| 3 | Industrials | 14.83% |
| 4 | Financials | 13.94% |
| 5 | Real Estate | 9.89% |
Similar funds
BI
FP
SFG
SCP
FFP
MI
PCMH
BONST
AltraVue Capital's Q2 2021 Portfolio in Review
As of Q2 2021, AltraVue Capital held 35 positions worth $564M, up 25% from $452M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
AltraVue Capital deployed $76.5M of net new capital in Q2 2021, opening 2 new positions and adding to 27 existing holdings. Its largest new stake was BGC Group: 2,300,820 shares worth $13M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Avid Bioservices, Inc. Common Stock, an estimated $3.27M trimmed.
- AltraVue Capital's largest Q2 2021 buy was BGC Group: 2,300,820 shares worth $13M.
- AltraVue Capital added most to StoneX in Q2 2021, an estimated $21.9M increase.
- AltraVue Capital's biggest Q2 2021 reduction was Avid Bioservices, Inc. Common Stock, cutting an estimated $3.27M.
- AltraVue Capital fully exited Bryn Mawr Bank Corp in Q2 2021, selling an estimated $18.2M.
- AltraVue Capital's ten largest holdings make up 53% of its $564M portfolio in Q2 2021.
- AltraVue Capital opened 2 new positions and closed 2 in Q2 2021.
- AltraVue Capital's portfolio value rose 25% quarter-over-quarter to $564M.
Based on AltraVue Capital's 13F filing for Q2 2021, filed 30 Jul 2021.